Representation of Enzymotec in its acquisition by Frutarom
Our firm represented Enzymotec (NASDAQ: ENZY), a nutritional ingredients and medical foods manufacturer, in its acquisition by Frutarom (TASE: FRUT), at a value of 290 million dollars. For more information (Hebrew), click here.